PHENTERMINE HYDROCHLORIDE

N/A

Manufactured by Aurolife Pharma, LLC

12,013 FDA adverse event reports analyzed

Last updated: 2026-04-15

About PHENTERMINE HYDROCHLORIDE

PHENTERMINE HYDROCHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Aurolife Pharma, LLC. The most commonly reported adverse reactions for PHENTERMINE HYDROCHLORIDE include DRUG INEFFECTIVE, NAUSEA, PAIN, FATIGUE, HEADACHE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for PHENTERMINE HYDROCHLORIDE.

Top Adverse Reactions

DRUG INEFFECTIVE537 reports
NAUSEA475 reports
PAIN462 reports
FATIGUE346 reports
HEADACHE335 reports
ANXIETY312 reports
VOMITING237 reports
DIZZINESS224 reports
OFF LABEL USE205 reports
CHRONIC KIDNEY DISEASE204 reports
DIARRHOEA203 reports
WEIGHT INCREASED203 reports
DYSPNOEA193 reports
DEPRESSION191 reports
ARTHRALGIA180 reports
ABDOMINAL PAIN165 reports
INSOMNIA162 reports
ACUTE KIDNEY INJURY160 reports
RASH158 reports
INJURY155 reports
CONSTIPATION154 reports
PRURITUS148 reports
PAIN IN EXTREMITY147 reports
ABDOMINAL PAIN UPPER138 reports
PULMONARY EMBOLISM137 reports
PRODUCT DOSE OMISSION ISSUE135 reports
CHEST PAIN133 reports
EMOTIONAL DISTRESS131 reports
DEEP VEIN THROMBOSIS128 reports
RENAL FAILURE128 reports
WEIGHT DECREASED126 reports
CHOLECYSTITIS CHRONIC123 reports
HYPERTENSION123 reports
BACK PAIN117 reports
ALOPECIA115 reports
FEELING ABNORMAL112 reports
DRUG INTERACTION109 reports
ASTHENIA108 reports
FALL108 reports
MIGRAINE107 reports
MUSCLE SPASMS107 reports
BLOOD PRESSURE INCREASED105 reports
PALPITATIONS105 reports
CHOLELITHIASIS102 reports
HYPERHIDROSIS101 reports
CONDITION AGGRAVATED100 reports
COVID 19100 reports
DRUG ABUSE99 reports
PSORIASIS98 reports
SOMNOLENCE96 reports
COMPLETED SUICIDE95 reports
SINUSITIS94 reports
HYPOAESTHESIA93 reports
PRODUCT USE IN UNAPPROVED INDICATION92 reports
MALAISE91 reports
PARAESTHESIA91 reports
DECREASED APPETITE89 reports
INJECTION SITE PAIN89 reports
TOXICITY TO VARIOUS AGENTS85 reports
HYPERSENSITIVITY77 reports
CEREBROVASCULAR ACCIDENT75 reports
COUGH73 reports
DYSPEPSIA73 reports
VISION BLURRED73 reports
GALLBLADDER DISORDER69 reports
URINARY TRACT INFECTION69 reports
PRODUCT USE ISSUE68 reports
DRUG HYPERSENSITIVITY67 reports
GASTROOESOPHAGEAL REFLUX DISEASE67 reports
MEMORY IMPAIRMENT67 reports
ABDOMINAL DISCOMFORT66 reports
PNEUMONIA66 reports
TREMOR66 reports
CHEST DISCOMFORT65 reports
HEART RATE INCREASED65 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION65 reports
ABDOMINAL DISTENSION64 reports
GAIT DISTURBANCE64 reports
PYREXIA64 reports
NASOPHARYNGITIS63 reports
IMPAIRED GASTRIC EMPTYING62 reports
DEHYDRATION61 reports
DEATH60 reports
PERIPHERAL SWELLING60 reports
STRESS60 reports
SUICIDAL IDEATION60 reports
CONFUSIONAL STATE59 reports
MYALGIA59 reports
DERMATITIS ATOPIC58 reports
OEDEMA PERIPHERAL56 reports
DRY MOUTH55 reports
SWELLING55 reports
DIABETES MELLITUS53 reports
MYOCARDIAL INFARCTION53 reports
OVERDOSE53 reports
TREATMENT FAILURE53 reports
LOSS OF CONSCIOUSNESS52 reports
DRY SKIN51 reports
INCORRECT DOSE ADMINISTERED51 reports
CARDIAC ARREST50 reports

Report Outcomes

Out of 6,104 classified reports for PHENTERMINE HYDROCHLORIDE:

Serious 56.9%Non-Serious 43.1%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female4,729 (84.6%)
Male771 (13.8%)
Unknown92 (1.6%)

Reports by Age

Age 48135 reports
Age 46121 reports
Age 35105 reports
Age 45104 reports
Age 53103 reports
Age 40101 reports
Age 3998 reports
Age 4798 reports
Age 3797 reports
Age 4997 reports
Age 5594 reports
Age 5093 reports
Age 5290 reports
Age 3489 reports
Age 3889 reports
Age 4188 reports
Age 5488 reports
Age 3085 reports
Age 3685 reports
Age 4484 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with PHENTERMINE HYDROCHLORIDE?

This profile reflects 12,013 FDA FAERS reports that mention PHENTERMINE HYDROCHLORIDE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for PHENTERMINE HYDROCHLORIDE?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, NAUSEA, PAIN, FATIGUE, HEADACHE, ANXIETY. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures PHENTERMINE HYDROCHLORIDE?

Labeling and FAERS entries often list Aurolife Pharma, LLC in connection with PHENTERMINE HYDROCHLORIDE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.